relaxants in the treatment of irritable bowel syndrome . aliment pharmacol ther . 2001 ; 15 ( 3 ) : 355-61 . 150. quartero ao , meineche-schmidt v , muris j , rubin g , wit n. bulking agents , antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome . the cochrane database of systematic reviews 2005 , issue 2. art . . : cd003460.pub2 . doi : 10.1002/14651858 . 106 • guía práctica clínica . sii151 . mitchell sa , mee as , smith gd , palmer kr , chapman rw . alverine citrate fails to relieve the symptoms of irritable bowel syndrome : results of double-blind , randomized , placebo-controlled trial . aliment pharmacol ther 2002 ; 16 ( 6 ) : 1187-95 . 152. lu cl , chen cy , chang fy , chang ss , kang lj , lu rh et . effect of calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome . j gastroenterol hepatol 2000 ; 15 ( 8 ) : 925-30 . 153. farthing mjg . irritable bowel syndrome : new pharmaceutical approaches to treatment . bailliere ’ s best pract res clin gastroenterol 1999 ; 13 : 461-71 . 154. evans bw , clark wk , moore dj , whorwell , pj . tegaserod for the treatment of irritable bowel syndrome . the cochrane database of systematic reviews 2004 , issue 1. art . . : cd003960.pub2 . doi : 10.1002/14651858 . 155. nyhlin h , bang c , elsborg l , silvennoinen j , holme i , ruegg p et . double-blind , placebo-controlled , randomized study to evaluate the efﬁ cacy , safety and tolerability of tegaserod in patients with irritable bowel syndrome . scand j gastroenterology 2004 ; 39 ( 2 ) : 119-26 . 156. brinker ad , mackey ac , prizont r. tegaserod and ischaemic colitis . n engl j med 2004 ; 351 ( 13 ) : 1361-2 . 157. joelsson be , shetzline ma , cunningham s. tegaserod and ischaemic colitis . n engl j med 2004 ; 351 ( 13 ) : 1363 . 158. cremonini f , delgado–aros s , camilleri m. efﬁ cacy of alosetron in irritable bowel syndrome : meta-analysis of randomized controlled trials . neurogastroenterol motil 2003 ; 15 : 79-86 . 159. chey wd , chey wy , heath at , dukes ge , carter eg , northcutt et . long-term safety and efﬁ cacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome . am j gastroenterol 2004 ; 99 : 2195-203 . 160. jackson jl , ’ malley pg , tomkins g , balden , santoro j , kroeneke k et . treatment of functional gastrointestinal disorders with antidepressant medications : meta-analysis . am j med 2000 ; 108 : 65-72 . 161. drossman da , toner bb , whitehead we , diamant ne , dalton cb , duncan s et . cognitive-behavioral therapy versus education and desipram versus placebo for moderate